A detailed history of Main Management ETF Advisors, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Main Management ETF Advisors, LLC holds 7,210 shares of LGND stock, worth $736,789. This represents 0.04% of its overall portfolio holdings.

Number of Shares
7,210
Holding current value
$736,789
% of portfolio
0.04%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$105.14 - $122.23 $758,059 - $881,278
7,210 New
7,210 $758,000

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.73B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Main Management ETF Advisors, LLC Portfolio

Follow Main Management ETF Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Main Management ETF Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Main Management ETF Advisors, LLC with notifications on news.